| Financial Year |
March 31 2023 |
| Monetary Funds |
620,678,128.30 |
| Held-for-trading Financial Assets |
58,318,164.93 |
| Notes Receivable |
42,895,366.16 |
| Accounts Receivable |
125,771,130.04 |
| Advances to Suppliers |
22,406,262.06 |
| Other Receivables |
2,615,785.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
291,027,586.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
33,474,912.16 |
| Total Current Assets |
1,277,182,110.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
175,614,759.80 |
| Under-construction Projects |
267,853,403.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
242,234,944.62 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
25,101,358.36 |
| Other Non-Current Assets |
197,666,361.36 |
| Sub-Total of Non-Current Assets |
910,448,399.94 |
| Total Assets |
2,187,630,510.30 |
| Short-Term Loans |
80,444,152.98 |
| Trading Financial liabilities |
-- |
| Notes Payable |
508,295,170.00 |
| Accounts Payable |
64,607,242.52 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,830,000.00 |
| Taxes Payable |
23,817,730.33 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,494,692.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,777,242.45 |
| Other Current Liabilities |
43,211,844.01 |
| Sub-Total of Current Liabilities |
743,463,830.92 |
| Long-term Loans |
125,537,983.94 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,381,562.97 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
221,107,897.05 |
| Total Liabilities |
964,571,727.97 |
| Paid-In Capital(Or Share Stock) |
200,010,000.00 |
| Capital Surplus |
305,107,195.86 |
| Surplus Reserve |
55,566,278.63 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
436,436,448.97 |
| Minority Stockholder's Interest |
225,938,858.87 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
997,119,923.46 |
| Owner's Equity（Stockholder's Equity） |
1,223,058,782.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,187,630,510.30 |
